[HTML][HTML] Adverse effects associated with long-term use of proton pump inhibitors
NMP Maideen - Chonnam medical journal, 2023 - ncbi.nlm.nih.gov
Abstract Proton Pump Inhibitors are used widely to manage many gastric acid-related
conditions such as gastroesophageal disease, gastritis, esophagitis, Barrett's esophagus …
conditions such as gastroesophageal disease, gastritis, esophagitis, Barrett's esophagus …
Proton pump inhibitors: Understanding the associated risks and benefits of long-term use
KM Thurber, AO Otto, SL Stricker - American Journal of Health …, 2023 - academic.oup.com
Abstract Purpose Proton pump inhibitors (PPIs) are widely prescribed medications. Various
adverse clinical effects of PPIs have been reported in the literature, particularly over the past …
adverse clinical effects of PPIs have been reported in the literature, particularly over the past …
[HTML][HTML] Proton pump inhibitor use is not strongly associated with SARS-CoV-2 related outcomes: a nationwide study and meta-analysis
SB Israelsen, MT Ernst, A Lundh, LF Lundbo… - Clinical …, 2021 - Elsevier
Background & Aims Proton pump inhibitor (PPI) use has been associated with increased risk
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe …
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe …
Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis
HB Kim, JH Kim, BJ Wolf - European Journal of Clinical Pharmacology, 2022 - Springer
Purpose Several observational studies have presented conflicting results on the association
between the use of proton pump inhibitors (PPIs) or histamine H2 receptor antagonist …
between the use of proton pump inhibitors (PPIs) or histamine H2 receptor antagonist …
A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps
E Eken, DS Estores, EJ Cicali… - Pharmacogenomics …, 2023 - Taylor & Francis
Proton pump inhibitors (PPIs) are commonly used medications to treat acid-related
conditions, including gastro-esophageal reflux disease (GERD). Gastroenterology …
conditions, including gastro-esophageal reflux disease (GERD). Gastroenterology …
Proton pump inhibitors and gastrointestinal symptoms among patients with COVID-19 infection
H Al-Momani, I Aolymat - Annals of Medicine, 2024 - Taylor & Francis
Introduction The administration of proton pump inhibitors (PPIs) is anticipated to elevate an
individual's susceptibility to enteric infections as a result of altering the gut flora. The …
individual's susceptibility to enteric infections as a result of altering the gut flora. The …
Proton Pump Inhibitors and Risk of COVID-19 Infection in Children
S Hirsch, E Liu, R Rosen - The Journal of Pediatrics, 2024 - Elsevier
Objective To evaluate the influence of proton pump inhibitor (PPI) use on COVID-19
susceptibility and severity in children. Study design This retrospective, case-control study …
susceptibility and severity in children. Study design This retrospective, case-control study …
Лекарственная безопасность в реальной клинической практике: акцент на протекторную терапию
ДИ Трухан, ДС Иванова - Фарматека, 2022 - elibrary.ru
Лекарственная безопасность является одним из приоритетных направлений
современной медицины и фармации-прежде всего в аспекте рациональной …
современной медицины и фармации-прежде всего в аспекте рациональной …
UV Spectrophotometric Method Development and validation of vonoprazan fumarate in Bulk and pharmaceutical Dosage form; Green Profile Evaluation Via eco-scale …
A Mohamed Saleh, AM El-Kosasy… - Egyptian Journal of …, 2023 - journals.ekb.eg
A novel, cost-effective, precise, and accurate UV spectrophotometric technique for
determining vonoprazan fumarate, a first-in-class potassium-competitive acid blocker, in …
determining vonoprazan fumarate, a first-in-class potassium-competitive acid blocker, in …
[HTML][HTML] Лекарственная безопасность: в фокусе долгосрочная терапия ингибиторами протонной помпы. Вероятные побочные эффекты
ДИ Трухан - Клинический разбор в общей медицине, 2024 - cyberleninka.ru
В настоящее время важным составляющим рациональной фармакотерапии является
лекарственная безопасность. Ингибиторы протонной помпы (ИПП) являются наиболее …
лекарственная безопасность. Ингибиторы протонной помпы (ИПП) являются наиболее …